Herbert Virgin, EVP, Research & CSO at Vir Biotechnology, Inc. (VIR), sold 1,375 shares at $32.46 ($45K) on 2022-01-25, disclosed to the SEC on 2022-01-26.
Scheduled sale ($45k) by EVP, Research & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2022-02-09 | $47K | — | Filing → |
| VIR | SELL | 2022-01-13 | $48K | — | Filing → |
| VIR | SELL | 2021-12-30 | $110K | — | Filing → |